Ayaz Najafov, Ph.D., led a UT Southwestern study that identified the protein responsible for rupturing cell membranes during necroptotic cell death. [Composite: DI Studio, source images, UTSW]
Eido Bio’s three co-founders are taking on menopause, research gaps, and a market where women’s health “sort of starts and stops with birth control.” The biotech startup is raising a Series A to launch clinical trials for a menopause treatment—and help shift the science toward women.
The award will help SMU biology professor Zhihao Wu determine if different "quality control pathways" in our bodies might be working together to repair damaged components in cells. The research could help lead to "new therapeutic targets" for hallmarks known to cause many human diseases, the university said.
Contracting Alzheimer's is the No. 1 fear of people over 65, says Sid O'Bryant, who wants to give primary physicians the ability to test for Alzheimer's with a blood test. That can offer peace of mind to many and earlier help for those who need it.
His groundbreaking research, which has revealed significant differences in biomarkers for the disease, could make the treatment of Alzheimer's more like that for cancer—a multi-dimensional "precision" approach.
The theater, with a new location in the Design District, is a stage and training center for the city’s comedians, but it’s also harnessing the power of laughter for therapeutic benefits.
Investors back North Texas startups and businesses with millions of dollars in funding. Here's a look at funding, mergers, and acquisitions involving companies and nonprofits with North Texas ties.
Cariloop’s health-care experts can be reached via telephone or video chat, and include nurses, social workers, case managers, therapists, and counselors.
Dallas-Fort Worth’s venture capital haul in the first nine months of 2026 fell almost 10% short of the same period last year, a new report shows.
On a positive note, though, the third quarter of this year was the fifth-best recorded in PitchBook-NVCA Venture Monitor’s dataset, which dates back to 2016....
Dallas-Fort Worth’s venture capital haul in the first nine months of 2026 fell almost 10% short of the same period last year, a new report shows.
On a positive note, though, the third quarter of this year was the fifth-best recorded in PitchBook-NVCA Venture Monitor’s dataset, which dates back to 2016....